FMP
NASDAQ
38.65 USD
1.2 (3.1%)
Dr. Mitchell H. Gold M.D.
Healthcare
Biotechnology
https://www.alpineimmunesciences.com
NASDAQ
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with Ab...
0001626199
US02083G1004
02083G100
188 East Blaine Street
206 788 4545
US
142
Jun 17, 2015
0001626199
NASDAQ
Biotechnology
Healthcare
02083G100
US02083G1004
US
38.65
1.13
1.13M
2.53B
-
6.71-42.88
-0.15
-
-
-
-
-60.39
-
https://www.alpineimmunesciences.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.